US FDA tells industry how to exchange info to meet new drug tracing law

The US Food and Drug Administration has released a draft guidance that explains how drug manufacturers, repackagers, wholesale distributors and dispensers should exchange transaction information, histories and statements when engaging in agreements involving certain prescription medicines to aid in tracing the products through the supply chain1.